Completed PHASE4 INTERVENTIONAL 2-arm NCT03881670

On-Eye Optical Quality of Lotrafilcon B Lenses Over 12 Hours

Sponsor: Alcon Research

Interventions Lotrafilcon B lotrafilcon B with Hydraluxe

Updated 10 times since 2019 Last updated: Mar 2, 2020 Started: Dec 7, 2018 Primary completion: Feb 8, 2019 Completion: Feb 8, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Hyperopia and Myopia and is currently completed. Alcon Research leads this study, which shows 10 recorded versions since 2018 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2023 — Jul 2024 [monthly]

Completed PHASE4
Dec 2022 — Jan 2023 [monthly]

Completed PHASE4
Jan 2021 — Dec 2022 [monthly]

Completed PHASE4

▶ Show 5 earlier versions

Apr 2020 — Jan 2021 [monthly]

Completed PHASE4
Mar 2020 — Apr 2020 [monthly]

Completed PHASE4
Feb 2020 — Mar 2020 [monthly]

Completed PHASE4
Jul 2019 — Feb 2020 [monthly]

Completed PHASE4

Status: Enrolling By Invitation → Completed
Apr 2019 — Jul 2019 [monthly]

Enrolling By Invitation PHASE4

First recorded

Dec 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Alcon Research
Indiana University

Data source: Indiana University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bloomington, United States